Jemperli Rectal Cancer Approval: FDA Clears Immunotherapy That May Spare Patients Surgery
The FDA has granted accelerated approval to GSK’s Jemperli for some patients with locally advanced rectal cancer, which may let them avoid surgery, radiation and chemotherapy. Who qualifies, and what the trial showed.